OGEN
Price
$0.34
Change
-$0.02 (-5.56%)
Updated
Nov 13 closing price
RNA
Price
$54.00
Change
+$1.50 (+2.86%)
Updated
Nov 14, 10:33 AM (EDT)
110 days until earnings call
Ad is loading...

OGEN vs RNA

Header iconOGEN vs RNA Comparison
Open Charts OGEN vs RNABanner chart's image
Oragenics
Price$0.34
Change-$0.02 (-5.56%)
Volume$320.02K
CapitalizationN/A
Avidity Biosciences
Price$54.00
Change+$1.50 (+2.86%)
Volume$2.2K
CapitalizationN/A
OGEN vs RNA Comparison Chart
Loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
OGEN vs. RNA commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGEN is a Hold and RNA is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (OGEN: $0.34 vs. RNA: $52.55)
Brand notoriety: OGEN and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OGEN: 70% vs. RNA: 248%
Market capitalization -- OGEN: $3.83M vs. RNA: $6.27B
OGEN [@Biotechnology] is valued at $3.83M. RNA’s [@Biotechnology] market capitalization is $6.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGEN’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • OGEN’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than OGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGEN’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 6 bullish TA indicator(s).

  • OGEN’s TA Score: 4 bullish, 3 bearish.
  • RNA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RNA is a better buy in the short-term than OGEN.

Price Growth

OGEN (@Biotechnology) experienced а +8.28% price change this week, while RNA (@Biotechnology) price change was +11.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

OGEN is expected to report earnings on May 15, 2023.

RNA is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($6.27B) has a higher market cap than OGEN($3.83M). RNA YTD gains are higher at: 480.663 vs. OGEN (-93.957). OGEN has higher annual earnings (EBITDA): -19.48M vs. RNA (-282.67M). RNA has more cash in the bank: 1.3B vs. OGEN (1.35M). OGEN has less debt than RNA: OGEN (0) vs RNA (8.38M). RNA has higher revenues than OGEN: RNA (10.6M) vs OGEN (0).
OGENRNAOGEN / RNA
Capitalization3.83M6.27B0%
EBITDA-19.48M-282.67M7%
Gain YTD-93.957480.663-20%
P/E RatioN/AN/A-
Revenue010.6M-
Total Cash1.35M1.3B0%
Total Debt08.38M-
FUNDAMENTALS RATINGS
OGEN: Fundamental Ratings
OGEN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
66
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGENRNA
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTTA3.420.06
+1.79%
Pasithea Therapeutics Corp
FTK7.500.05
+0.67%
Flotek Industries
CION11.37-0.03
-0.26%
CION Investment Corp
TFX193.98-1.60
-0.82%
Teleflex
CWK14.44-0.18
-1.23%
Cushman & Wakefield plc

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-6.59%
ATHA - OGEN
34%
Loosely correlated
-8.75%
SRPT - OGEN
30%
Poorly correlated
-1.61%
CHRS - OGEN
27%
Poorly correlated
-5.40%
RVNC - OGEN
26%
Poorly correlated
+2.91%
RNA - OGEN
26%
Poorly correlated
+12.45%
More